Circulating Tumor Cells and Cancer Stem Cells Market Report

Global and Region Circulating Tumor Cells and Cancer Stem Cells Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：168
  • REPORT CODE：GMM911549
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Circulating Tumor Cells and Cancer Stem Cells market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Circulating Tumor Cells and Cancer Stem Cellsmarket, defines the market attractiveness level of Circulating Tumor Cells and Cancer Stem Cells market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Circulating Tumor Cells and Cancer Stem Cells industry, describes the types of Circulating Tumor Cells and Cancer Stem Cells market, the applications of major players and the market size, and deeply analyzes the current situation of the global Circulating Tumor Cells and Cancer Stem Cells market and the development prospects and opportunities of Circulating Tumor Cells and Cancer Stem Cells industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Circulating Tumor Cells and Cancer Stem Cells market in Chapter 13.

    By Player:

    • Epic Sciences

    • Rarecells

    • AVIVA Biosciences

    • Cynvenio Biosystems

    • Advanced Cell Diagnostics

    • Fluxion Biosciences

    • CellTraffix

    • Janssen Diagnostics

    • ApoCell

    • QIAGEN Hannover

    • Silicon Biosystems

    By Type:

    • Cell Enrichment

    • Detection

    • CTC Analysis

    By End-User:

    • Hospital

    • NSC

    • Medical Research Institute

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Circulating Tumor Cells and Cancer Stem Cells Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Circulating Tumor Cells and Cancer Stem Cells Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Circulating Tumor Cells and Cancer Stem Cells Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Circulating Tumor Cells and Cancer Stem Cells Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Circulating Tumor Cells and Cancer Stem Cells Market Analysis and Outlook to 2022

    • 7.1 Global Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.2 United States Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.3 Europe Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.4 China Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.5 Japan Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.6 India Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    • 7.7 South Korea Circulating Tumor Cells and Cancer Stem Cells Consumption (2017-2022)

    8 Region and Country-wise Circulating Tumor Cells and Cancer Stem Cells Market Analysis and Outlook to 2028

    • 8.1 Global Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.2 United States Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.3 Europe Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.4 China Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.5 Japan Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.6 India Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    • 8.7 South Korea Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast (2022-2028)

    9 Global Circulating Tumor Cells and Cancer Stem Cells Market Outlook by Types and Applications to 2022

    • 9.1 Global Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Cell Enrichment Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Detection Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global CTC Analysis Consumption and Growth Rate (2017-2022)

    • 9.2 Global Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global NSC Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Medical Research Institute Consumption and Growth Rate (2017-2022)

    10 Global Circulating Tumor Cells and Cancer Stem Cells Market Outlook by Types and Applications to 2028

    • 10.1 Global Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Cell Enrichment Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Detection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global NSC Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Medical Research Institute Consumption Forecast and Growth Rate (2022-2028)

    11 Global Circulating Tumor Cells and Cancer Stem Cells Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Circulating Tumor Cells and Cancer Stem Cells Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Circulating Tumor Cells and Cancer Stem Cells Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Circulating Tumor Cells and Cancer Stem Cells Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Circulating Tumor Cells and Cancer Stem Cells Market Competitive Analysis

    • 14.1 Epic Sciences

      • 14.1.1 Epic Sciences Company Details

      • 14.1.2 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.2 Rarecells

      • 14.2.1 Rarecells Company Details

      • 14.2.2 Rarecells Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Rarecells Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.3 AVIVA Biosciences

      • 14.3.1 AVIVA Biosciences Company Details

      • 14.3.2 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.4 Cynvenio Biosystems

      • 14.4.1 Cynvenio Biosystems Company Details

      • 14.4.2 Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.5 Advanced Cell Diagnostics

      • 14.5.1 Advanced Cell Diagnostics Company Details

      • 14.5.2 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.6 Fluxion Biosciences

      • 14.6.1 Fluxion Biosciences Company Details

      • 14.6.2 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.7 CellTraffix

      • 14.7.1 CellTraffix Company Details

      • 14.7.2 CellTraffix Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 CellTraffix Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.8 Janssen Diagnostics

      • 14.8.1 Janssen Diagnostics Company Details

      • 14.8.2 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.9 ApoCell

      • 14.9.1 ApoCell Company Details

      • 14.9.2 ApoCell Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 ApoCell Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.10 QIAGEN Hannover

      • 14.10.1 QIAGEN Hannover Company Details

      • 14.10.2 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • 14.11 Silicon Biosystems

      • 14.11.1 Silicon Biosystems Company Details

      • 14.11.2 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Circulating Tumor Cells and Cancer Stem Cells

    • Figure Circulating Tumor Cells and Cancer Stem Cells Picture

    • Table Global Circulating Tumor Cells and Cancer Stem Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells and Cancer Stem Cells Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Circulating Tumor Cells and Cancer Stem Cells Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Circulating Tumor Cells and Cancer Stem Cells Consumption by Country (2017-2022)

    • Figure United States Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Table Europe Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Japan Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure India Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure South Korea Circulating Tumor Cells and Cancer Stem Cells Consumption and Growth Rate (2017-2022)

    • Figure Global Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast by Country (2022-2028)

    • Figure United States Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Circulating Tumor Cells and Cancer Stem Cells Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cell Enrichment Consumption and Growth Rate (2017-2022)

    • Figure Global Detection Consumption and Growth Rate (2017-2022)

    • Figure Global CTC Analysis Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global NSC Consumption and Growth Rate (2017-2022)

    • Figure Global Medical Research Institute Consumption and Growth Rate (2017-2022)

    • Figure Global Cell Enrichment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Detection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global CTC Analysis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global NSC Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Medical Research Institute Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Circulating Tumor Cells and Cancer Stem Cells Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Circulating Tumor Cells and Cancer Stem Cells Export by Region (Top 5 Countries) (2017-2028)

    • Table Epic Sciences (Foundation Year, Company Profile and etc.)

    • Table Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Epic Sciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Rarecells (Foundation Year, Company Profile and etc.)

    • Table Rarecells Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rarecells Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table AVIVA Biosciences (Foundation Year, Company Profile and etc.)

    • Table AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table AVIVA Biosciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Cynvenio Biosystems (Foundation Year, Company Profile and etc.)

    • Table Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cynvenio Biosystems Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Advanced Cell Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Advanced Cell Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Fluxion Biosciences (Foundation Year, Company Profile and etc.)

    • Table Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fluxion Biosciences Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table CellTraffix (Foundation Year, Company Profile and etc.)

    • Table CellTraffix Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table CellTraffix Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Janssen Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Diagnostics Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table ApoCell (Foundation Year, Company Profile and etc.)

    • Table ApoCell Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table ApoCell Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table QIAGEN Hannover (Foundation Year, Company Profile and etc.)

    • Table QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table QIAGEN Hannover Circulating Tumor Cells and Cancer Stem Cells Product and Service

    • Table Silicon Biosystems (Foundation Year, Company Profile and etc.)

    • Table Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Sales, Price, Value and Gross Profit (2017-2022)

    • Table Silicon Biosystems Circulating Tumor Cells and Cancer Stem Cells Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US